Gene Therapy Drug Pipeline Analysis


Naperville, IL -- (SBWIRE) -- 06/02/2014 -- Reportstack, provider of premium market research reports announces the addition of Gene Therapy Drug Pipeline Analysis market report to its offering
Gene Therapy Drug Pipeline Analysis by PNS Pharma gives comprehensive insight on the various drugs being developed for the treatment of multiple disease based upon Gene Therapy. Research report covers all the ongoing drug development in various development phases. Each drug profiles include detailed information like: Originator, Owner, Collaborator, Technology Provider, Licensee, Development Phase, Development Indications, Mechanism of Action, Country of Development and detailed analysis on the development process. Insight for each drug profile in development phase enables the reader to identify and understand the Gene Therapy associated with the various diseases.

This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the Gene Therapy based drug development process. Following parameters for each drug profile in development phase are covered in Gene Therapy Drug Pipeline Analysis research report:

Drug Profile Overview

Alternate Names for Drug

Active Indication Phase of Development

Mechanism of Action

Country for Clinical Trial

Owner / Originator/ Licensee/Collaborator

Administrative Route

Drug Class

ATC Codes

Number of Drug Profiles in Development Phases:

Research: 4

Preclinical: 49

Phase I: 22

Phase I/II: 14

Phase II: 22

Phase III: 2

Preregistration: 1

Registered: 1

Marketed: 1

To view the table of contents for this market research report please visit
Roger Campbell
United States
Ph: 888-789-6604